X4 Pharmaceuticals annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
X4 Pharmaceuticals Revenue Growth & History (XFOR)
X4 Pharmaceuticals reported $35.1M in revenue for fiscal 2025, an increase of 1273.21% from the previous fiscal year.
View full X4 Pharmaceuticals company overviewX4 Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $35.1M | $32.6M | +1273.21% |
| 2024 | 2024-12-31 | $2.6M | $2.6M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | −$3.0M | −100.00% |
| 2020 | 2020-12-31 | $3.0M | $3.0M | — |
| 2019 | 2019-12-31 | $0 | $0 | — |
| 2018 | 2018-12-31 | $0 | — | — |
X4 Pharmaceuticals quarterly revenue
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.8M | $6.8M | +346.33% |
| Q1 2026 | 2026-03-31 | $2.7M | −$26.1M | −90.60% |
| Q4 2025 | 2025-12-31 | $2.6M | $1.1M | +79.08% |
| Q3 2025 | 2025-09-30 | $1.8M | $1.2M | +215.18% |
| Q2 2025 | 2025-06-30 | $2.0M | $1.4M | +250.44% |
| Q1 2025 | 2025-03-31 | $28.8M | $28.8M | — |
| Q4 2024 | 2024-12-31 | $1.4M | — | — |
| Q3 2024 | 2024-09-30 | $560,000 | $560,000 | — |
| Q2 2024 | 2024-06-30 | $563,000 | $563,000 | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q4 2021 | 2021-12-31 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $0 | −$3.0M | −100.00% |
| Q4 2020 | 2020-12-31 | $0 | $0 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $3.0M | $3.0M | — |
| Q4 2019 | 2019-12-31 | $0 | −$3.5M | −100.00% |
| Q3 2019 | 2019-09-30 | $0 | — | — |
| Q2 2019 | 2019-06-30 | $0 | — | — |
| Q1 2019 | 2019-03-31 | $0 | — | — |
| Q4 2018 | 2018-12-31 | $3.5M | — | — |
X4 Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue grew from $3.0M to $35.1M, a compound annual growth rate of 63.56%. X4 Pharmaceuticals's latest reported quarter, Q2 2026, generated $8.8M in revenue, an increase of 346.33% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review X4 Pharmaceuticals source filings ↗